Home > News > University of Canterbury commisions an IBM Blue Gene/L supercomputer
May 30th, 2007
University of Canterbury commisions an IBM Blue Gene/L supercomputer
The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington and AUT University will be foundation partners in the Blue Gene project.
Blue Gene is optimised for bandwidth, scalability and the ability to handle large amounts of data. Its modular design allows for computing components - or "racks" - to be added as needed.
The Blue Gene installed at the University of Canterbury will have two racks and will be the most powerful system in New Zealand. It will rank among the Top 100 most powerful supercomputers in the world, based on projections for the TOP500 Supercomputers list to be published in June 2007.
NanoTecNexus Launches New App for Learning About Nanotechnology—STEM Education Project Spearheaded by Interns February 26th, 2015
SUNY Poly CNSE Researchers and Corporate Partners to Present Forty Papers at Globally Recognized Lithography Conference: SUNY Poly CNSE Research Group Awarded Both ‘Best Research Paper’ and ‘Best Research Poster’ at SPIE Advanced Lithography 2015 forum February 25th, 2015
KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015
Minus K Technology Announces Its 2015 Vibration Isolator Educational Giveaway to U.S. Colleges and Universities February 18th, 2015
Moving molecule writes letters: Caging of molecules allows investigation of equilibrium thermodynamics February 27th, 2015
Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015
Bruker-Sponsored Sixth AFM BioMed Conference Highlights Increasing Impact of AFM in Biological Applications February 26th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015